Incruse Ellipta: Medgend

Search instead for increase ellipta

Incruse Ellipta FDA Approved Drugs

INCRUSE ELLIPTA [Umeclidinium Bromide^{C₂₉H₃₄NO₂Br}]

eq 62.5mcg base/inh (inhalation powder)

Glaxo Grp England^{Apr 30, 2014}

Indicated for the long-term, once-daily, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (copd), including chronic bronchitis and/or emphysema..

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.